Close Menu

NEW YORK – Laboratory Corporation of America said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for an RNA extraction method for use in SARS-CoV-2 testing.

According to the Burlington, North Carolina-based company, the method uses heat to trap viral particles, which eliminates the need to use RNA extraction reagents to capture viral nucleic acid for testing, improving turnaround time and reducing reliance on extraction reagents, which have proved a supply chain bottleneck at points in the pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.